ERBB2 and prostate carcinoma: Physicians can use salivary biomarkers for detecting other cancers, such as prostate-specific antigens for prostate cancer, human epidermal growth factor receptor 2 (HER2/neu) for breast cancer, and cancer antigens for other malignancies.